Concepedia

Phase I trial of ZD9331, a non-polyglutamatable thymidylate synthase inhibitor given as a 5-day continuous infusion every 3 weeks

José Trigo, Clarence E. Rees, Philip Beale, F. Mitchell, A.L. Jackman, Rhodri Smith, Michael G. Hutchison, M. Katharine Smith, I. Judson

European Journal of Cancer · 1999 · 12 citations · 0 references

DOI

Concepts